spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  New Leaf Venture Partners 

 HSMN NewsFeed - 1 Jun 2021
Neurana Pharmaceuticals Appoints Georgia Erbez and Liz Cermak to Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 7 Nov 2019
Neurana Pharmaceuticals Appoints Randall Kaye, M.D., Chief Medical Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 12 Nov 2018
Arix Bioscience plc: Arix Participates in Harpoon $70m Series C Investment Round
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 4 Apr 2018
Arvinas Completes $55 Million Series C Financing to Advance Protein Degradation Platform
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 19 May 2017
Iterum Secures $65 Million in Series B Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 4 Nov 2016
ReShape Medical, Inc. Unveils US Commercial Data Demonstrating Increased Weight Loss with ReShape(R) Dual Balloon
Devices Gastroenterology
 HSMN NewsFeed - 10 Jun 2016
Merck to Acquire Afferent Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 10 May 2016
Aptinyx Raises $65 Million in Series A Financing to Advance Therapies for Neurological Disorders
Biopharmaceuticals Neurology Venture Capital Personnel
 HSMN NewsFeed - 3 Dec 2015
True North Therapeutics Announces $40 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 21 Oct 2015
Arvinas Secures $41.6M Series B Financing - Appoints New Board Members
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 21 Sep 2015
Deciphera Pharmaceuticals Announces $75 Million Series B Financing to Advance Novel Oncology Pipeline
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 18 Aug 2015
WAVE Life Sciences Raises $66 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Jun 2015
Advanced Cell Diagnostics Completes $22 Million Series C Equity Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 8 Dec 2014
CardioKinetix Completes $50 Million Financing and Signs Agreement With Edwards Lifesciences, Including Exclusive Option to Purchase
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 21 Aug 2014
Direct Flow Medical(R), Inc. Receives CE Mark for 23mm Valve and for Implantation of All Sizes of Its Transcatheter Aortic Heart Valve Without Use of Contrast
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 18 Feb 2014
Versartis Secures $55 Million in Series E Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 Feb 2014
Principia Biopharma Expands Executive Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jan 2014
IlluminOss Medical Announces Spanish and Israeli Launch of Photodynamic Bone Stabilization System (PBSS)
Devices Orthopaedic Distribution
 HSMN NewsFeed - 24 Oct 2013
IlluminOss Medical Appoints Martin Aschenbrener as Vice President of Finance
Devices Orthopaedic Personnel
 HSMN NewsFeed - 14 Oct 2013
CardioKinetix Announces First Heart Failure Patients Treated in China With Novel Minimally Invasive Structural Heart Device
Devices Interventional Cardiology
 HSMN NewsFeed - 10 Sep 2013
First Patient Enrolls in U.S. SALUS Trial Evaluating Direct Flow Medical(R) Transcatheter Aortic Heart Valve System
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Aug 2013
CardioKinetix Announces First Heart Failure Patients Treated in Asia with Minimally Invasive Structural Heart Device
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Feb 2013
Aviir Secures Second $10 Million Financing Tranche; Attracts New Investor Group
Diagnostics Cardiology Venture Capital
 HSMN NewsFeed - 28 Jan 2013
Direct Flow Medical(R) Receives CE Mark for Transcatheter Aortic Heart Valve System That Virtually Eliminates Aortic Regurgitation
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 15 Jan 2013
Versartis Closes $25 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 Nov 2012
Pearl Therapeutics Raises $65 Million Series D to Start PT003 Phase 3
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Oct 2012
Principia Biopharma Secures $12.5M Second Tranche In Series A Financing, Expands Senior Management Team
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 24 Oct 2012
CardioKinetix Announces Data From Latest European Study of Heart Failure Patients With First-of-Its-Kind Percutaneous Treatment
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Oct 2012
Direct Flow Medical(R) Transcatheter Aortic Valve System Shown To Virtually Eliminate Aortic Regurgitation With No Vascular Complications In DISCOVER CE Mark Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Oct 2012
CardioKinetix Receives CE Mark Approval for Full Range of Sizes for First-of-Its-Kind Percutaneous Treatment for Heart Failure
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 7 Jun 2012
CardioKinetix Initiates European Post-Market Trial of First-of-Its-Kind Minimally Invasive Treatment for Heart Failure in Germany
Devices Interventional Cardiology
 HSMN NewsFeed - 18 May 2012
CardioKinetix Announces Positive Two-Year Clinical Data for First-of-Its-Kind Minimally Invasive Treatment for Heart Failure
Devices Interventional Cardiology
 HSMN NewsFeed - 7 May 2012
CardioKinetix Announces Late Breaking EuroPCR Session Featuring First-of-Its-Kind Minimally Invasive Treatment for Heart Failure
Devices Interventional Cardiology
 HSMN NewsFeed - 7 May 2012
Maria Sainz Joins CardioKinetix as President and Chief Executive Officer
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 14 Feb 2012
Biogen Idec to Acquire Stromedix
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 10 Jan 2012
Interwest Partners Expands Medical Devices Team
Devices Venture Capital Personnel
 HSMN NewsFeed - 20 Sep 2011
CardioKinetix Inc. Raises $44 Million in Series E Financing
Devices Cardiology Venture Capital Personnel
 HSMN NewsFeed - 16 May 2011
Neuronetics, Inc. Raises $30 Million in Series E Financing
Devices Neurology Venture Capital
 HSMN NewsFeed - 19 Apr 2011
Durata Therapeutics Initiates Phase 3 Study of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Biopharmaceuticals
 HSMN NewsFeed - 16 Feb 2011
Versartis Completes $21 Million Series B Financing
Biopharmaceuticals Endocrinology Venture Capital
 HSMN NewsFeed - 2 Feb 2011
Spine Wave Announces Completion of $17.5M Financing
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 1 Feb 2011
Spiracur Announces Close of $35 Million Funding
Devices Wound Care Venture Capital
 HSMN NewsFeed - 7 Jan 2011
Hologic Acquires Interlace Medical
Devices Surgery Mergers & Acquisitions
 HSMN NewsFeed - 19 Oct 2010
Pearl Therapeutics Raises $69 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 Oct 2010
New Leaf Venture Partners Invests in $35.4 (£22.4) Million Series A Financing of Convergence Pharmaceuticals
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 Sep 2010
Relypsa Raises $70 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 Jun 2010
Altura Medical Completes $20 Million Round of Financing
Devices Interventional Venture Capital
 HSMN NewsFeed - 18 Mar 2010
Dr. Thomas Hofstaetter Named President and CEO of VaxInnate; Dr. Alan Shaw Assumes New Role as Chief Scientific Officer and Chairman of the Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Feb 2010
Tioga Pharmaceuticals, Inc. Raises $18 Million to Fund Phase 3 Clinical Trial in Irritable Bowel Syndrome
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Jan 2010
Afferent Pharmaceuticals Names Bruce G. McCarthy, M.D., as CEO
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 21 Dec 2009
Newly Formed Durata Therapeutics Acquires Pfizer's Vicuron Subsidiary
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 16 Dec 2009
Roche Licenses First-in-Class Treatments for Chronic Pain to Afferent Pharmaceuticals; Afferent Secures $23 Million in Series A Financing
Biopharmaceuticals Licensing Venture Capital
 HSMN NewsFeed - 5 Oct 2009
Direct Flow Medical Presents Twelve Month Clinical Results with Their Percutaneous Aortic Valve System at TCT
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Aug 2009
XDx Completes $14.4 Million Series G Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 20 May 2009
Direct Flow Medical Completes First Human Use of 18F Percutaneous Aortic Valve System
Devices Interventional Cardiology
 HSMN NewsFeed - 6 May 2009
VaxInnate Corporation Closes $30 Million Round of Financing; Wellcome Trust Leads Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 Apr 2009
Visiogen Secures $40 Million in Equity Financing
Devices Ophthalmology Venture Capital
 HSMN NewsFeed - 23 Sep 2008
Oriel Therapeutics Appoints Richard Fuller as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Aug 2008
Stromedix Receives Orphan Drug Designation for STX-100 in Chronic Allograft Nephropathy
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Apr 2008
CoNCERT Pharmaceuticals Raises $37 Million in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Feb 2008
Artisan Pharma's Lead Product, ART-123, Approved in Japan
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 6 Feb 2008
POINT Biomedical Corp. First Tranche of $50 Million in Equity Financing
Biopharmaceuticals Cardiology Venture Capital
 HSMN NewsFeed - 29 Oct 2007
Relypsa Formed With $33 Million Series A Funding to Discover and Develop Polymeric Drugs
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Oct 2007
Direct Flow Medical Raises $27 Million and Initiates European Clinical Trial
Devices Cardiology Venture Capital
 HSMN NewsFeed - 10 Oct 2007
New Leaf Venture Partners Closes $450 Million Healthcare Fund
Venture Capital
 HSMN NewsFeed - 1 May 2007
Aspire Medical Appoints Roseanne Varner as President and CEO
Devices Personnel
 HSMN NewsFeed - 6 Mar 2007
TransOral Pharmaceuticals Raises $40 Million in Series D Financing. Proceeds Will Be Used to Complete Intermezzo(TM) Phase 3 Clinical Trials and File NDA
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 Dec 2006
Cerexa to Be Acquired by Forest Laboratories for $480 Million Plus Potential $100 Million Milestone Payment
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 30 Nov 2006
Concert Pharmaceuticals Raises $48.5 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Sep 2006
Artisan Pharma, Inc. Raises $39 Million in a Series A Financing Led by NGN Capital LLC
Biopharmaceuticals Venture Capital
Return to NewsFeed  

 Additional items found! 4

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 4 additional stories matching:
New Leaf Venture Partners
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!